GSK

|

Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market

GSK plans to sell generic versions of the inhalers, but many are still worried about insurance coverage for alternatives.

Dec 29, 2023

|

Naveen Athrappully

Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market

Dec 29

|

Vaccines

|

Mimi Nguyen Ly

FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine

Mar 02, 2023

|

Mimi Nguyen Ly

FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine

Mar 02

|

Companies

|

Reuters

GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback

Nov 11, 2022

|

Reuters

Nov 11

|

Companies

|

Reuters

GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall

Nov 07, 2022

|

Reuters

Nov 07

|

Companies

|

Reuters

GSK Says FDA Approves Kidney Disease Drug for Children

Jul 29, 2022

|

Reuters

GSK Says FDA Approves Kidney Disease Drug for Children

Jul 29

|

Companies

|

Reuters

Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off

Jun 01, 2022

|

Reuters

Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off

Jun 01

|

Economy

|

Reuters

GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead

Feb 03, 2022

|

Reuters

GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead

Feb 03

|

Companies

|

Reuters

GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets

Jan 18, 2022

|

Reuters

GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets

Jan 18

|

AMERICA

|

Tammy Hung

Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO

Jan 13, 2022

|

Tammy Hung

Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO

Jan 13

|

Health

|

Reuters

GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi

Sep 28, 2021

|

Reuters

GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi

Sep 28

|

Europe

|

Reuters

EU Signs Deal With GSK for Supply of Potential COVID-19 Drug

Jul 28, 2021

|

Reuters

EU Signs Deal With GSK for Supply of Potential COVID-19 Drug

Jul 28

|

US-China Relations

|

Frank Fang

Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK

Jul 17, 2019

|

Frank Fang

Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK

Jul 17

|

Companies

|

Reuters

Drugmaker GSK to Eliminate 650 US Jobs

Sep 05, 2018

|

Reuters

Sep 05

|

|

Matthew Robertson

British Private Eye in China Prosecuted for Knowing Too Much

A British private investigator and his Chinese-American wife are being prosecuted in Shanghai, ostensibly for obtaining private information of Chinese citizens.

Jul 14, 2014

|

Matthew Robertson

British Private Eye in China Prosecuted for Knowing Too Much

Jul 14

|

LATEST

Doctors Express ‘Huge Shock’ as Manufacturer Pulls Popular Asthma Inhalers From Market

FDA Panel Endorses GSK Vaccine for RSV in Older Adults, a Day After Recommending Pfizer’s Vaccine

GSK’s Oncology Business Suffers Fresh Blow With Zejula Setback

GSK’s Blood Cancer Drug Fails Main Goal of Trial, Shares Fall

GSK Says FDA Approves Kidney Disease Drug for Children

Pfizer to Exit GSK’s Consumer Health Arm After Spin-Off

GSK to Get $1.25 Billion to Settle HIV Drug Patent Row With Gilead

GSK Rejects 50-Billion-Pound Unilever Offer for Consumer Assets

Government Control Led to Lack of Monoclonal Antibodies, Says Medical Supplies CEO

GSK to Develop Longer-Acting Therapy for HIV With Japan’s Shionogi

EU Signs Deal With GSK for Supply of Potential COVID-19 Drug

Swiss Authorities Approve US Extradition Request for Chinese Scientist Accused of Stealing Trade Secrets From GSK

Drugmaker GSK to Eliminate 650 US Jobs

British Private Eye in China Prosecuted for Knowing Too Much